![]() |
|
|||
Simple ways to help improve your loved one's quality of life through diet, exercise, support groups and more. Get useful information on PD, support groups, and other resources for patients and caregivers and more. ![]() |
If you’ve just been diagnosed with Parkinson’s disease, you most likely have many questions. The good news is that treatment for this disease is getting better every day, and most people who have the disease can keep enough control over their symptoms to live a long, productive life. Like most people, you probably want to know more about the disease and what your treatment options are. You may also have heard about MIRAPEX, and might want to know more about it and how it works. The menu of links at left has been created with you in mind. It quickly points you to the information you want to know most. Plus, we’ve given you other links that might be helpful, like tips for your next doctor visit and how to live well with Parkinson’s disease. We hope this information will be helpful to you. Of course, you can always browse the site in any order you like. If you still have questions, talk to your doctor. And be sure to ask your doctor if MIRAPEX may be right for you. |
![]() |
Important Information about MIRAPEX: MIRAPEX® (pramipexole dihydrochloride) Tablets are indicated for the treatment of the signs and symptoms of idiopathic Parkinson’s disease. Patients have reported falling asleep without any warning signs during activities of daily living, including operation of a motor vehicle, which sometimes resulted in accidents. Hallucinations and dizziness upon standing may occur. The most commonly reported adverse events in early and late disease in clinical trials were dizziness, involuntary movement, hallucinations, headache, difficulty falling asleep, sleepiness and nausea. Patients and caregivers should be informed that impulse control disorders/compulsive behaviors may occur while taking medicines, including pramipexole, to treat Parkinson's disease. Please see full Prescribing Information. This information is intended for US residents only.
Copyright © 2007 Boehringer Ingelheim Pharmaceuticals, Inc. All rights
reserved. |